Go behind the scenes of clinical research with some of the leading minds in life sciences. Discover what’s happening in today’s world of clinical trials, the technology and ideas transforming them, and why it matters for each and every one of us. This is Clinical Minds, presented by Medidata.
Adopting Clinical Trial Technology: The Key to Success for Patients, Sites, & Researchers
Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials.
In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Irfan Khan, MD, founder and CEO of Circuit Clinical, to discuss clinical trial technology adoption across patients, care teams, trial sites, and researchers and the need for industry buy-in, especially around decentralized trial technology.
Dr. Khan is a cardiologist who has served as a principal investigator on both therapeutic and device clinical trials for more than a decade. He is passionate about improving diversity in clinical trials, increasing community engagement, and fostering the patient experience through education and empowerment. Over the last six years, he has overseen Circuit Clinical’s growth to reach more than 2.5 million potential participants across 60+ active research sites.
Clinical Trial Patient Recruitment: One Size Does Not Fit All
When it comes to patient recruitment strategies, there is no one-size-fits-all approach. So how do you raise clinical trial awareness and develop innovative solutions for recruitment that break down silos and improve patient outreach?
In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Tricia Barrett, Chief Operating Officer at Praxis & Crowley Webb, to discuss what an efficient direct-to-patient recruitment campaign looks like. Learn how to drive diverse patient recruitment by moving from transactional, traditional strategies to innovative, people-focused approaches.
Tricia oversees all Praxis operations from proposal generation through completed, enrolled studies. Her experience encompasses a wide range of therapeutic areas and strategies. Tricia brings a unique approach to patient recruitment that focuses on sound science and innovative execution, while always keeping the patient experience top of mind.
The Power of Patient Insights: Solutions Designed Side-by-Side with Patients
Is your product truly inspired by patient insights? Patient centricity is more than just a buzzword: it’s a movement. So how do you make sure your products improve the patient experience in clinical trials and alleviate patient burden?
In this episode, industry experts Kelly McKee and Alicia Staley are joined by Paul Chang, VP of Design at Medidata, to map the future of product design in clinical trials. Learn how Medidata’s patient advocates directly impact UX design to drive patient centricity across products.
Paul has spent over 20 years across a diverse range of product and design initiatives. In his role as VP of Design, he is responsible for how products and services are experienced by customers, partners, clinicians, and patients; this includes leading design strategy and building Medidata’s capabilities and reputation as a design-driven company.
Give Me My Data: How Patient Access Builds Trust in Clinical Trials
As a patient, who owns your clinical trial data? Patient participation is the foundation of clinical trial research. But in today’s world, patient access to data is limited and siloed. How do researchers ensure patient data return is the standard operating procedure and information is shared with trial participants?
In this episode, Craig Lipset sits down with Kelly McKee and Alicia Staley of Medidata to discuss the challenges of data return and how to improve patient access and clinical trial data transparency.
Craig is an advisor, educator, advocate, and innovator focused on novel solutions for clinical trials and medicine development. He is the founder of Clinical Innovation Partners, Co-Chair for the Decentralized Trials & Research Alliance, and Vice Chair of the MedStar Health Research Institute.
How the FDA is focused on improving clinical trial access, enrollment, and enhancing public trust and education
The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity.
How to better bridge the gaps in Latinx patients clinical trial participation with Dr. Fabian Sandoval
The simplest thing to do is to find out what kind of patients you have. Find out what cultures they are. Learn about the culture. Learn to connect. Be a human. Don't just be a robot that does science. Don't speak above someone's level. Speak to them. Put yourself in that patient's shoes, and speak to them kindly,” says Dr. Fabian Sandoval, CEO and Research Director of the Emerson Clinical Research Institute in Washington, DC, and Emmy winner and host of the weekly medical TV show "Tu Salud, Tu Familia
Great podcast tailored to Clinical Trials
This is one of the only podcasts that focuses on the business of clinical trials which is really good for all of us trying to bring new treatments to market. Well produced, high quality and Informative!